Shuttle Pharmaceuticals (SHPH) shares saw a dip despite receiving a new patent for its selective histone deacetylase (HDAC) inhibitors. The patent covers inhibitors designed to fight cancer and other diseases. Despite earlier gains, the stock is currently trading lower. Benzinga explores the factors investors should consider when evaluating SHPH as a potential investment.
Results for: Patent
Digital Ally, Inc. (DGLY) saw its shares surge in after-hours trading after the company secured a U.S. patent for a technology that tracks and analyzes driver behavior within fleets of vehicles. The patent details a system that monitors vehicle data, analyzes driver behavior, and generates driver profiles. This news has sparked significant investor interest, driving heavy trading volume.
Apple has filed a patent for a modular iPhone that could allow users to replace the back panel with customizable components, such as extra batteries, health sensors, cameras, and more. This innovative concept could significantly change how we use our smartphones.